EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention

Ezgi Eroglu iD, Nusin Harmanci iD

Basic & Clinical Pharmacology & Toxicology · 2025-10 · 137 (4)

DOI: 10.1111/bcpt.70107 ↗

At a glance

Übersichtsarbeit in Basic & Clinical Pharmacology & Toxicology, published online on 2025-09-08. Written by Ezgi Eroglu and 1 co-authors. Institution: Department of Clinical Trials, Turkish Medicines and Medical Devices Agency, Ankara, Turkey. Major MEDLINE topics: Neurodegenerative Diseases, Molecular Targeted Therapy. Cited 16 times so far (Crossref); 80 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis and frontotemporal dementia represent a significant global health burden with limited therapeutic options. Current treatments are primarily symptomatic and fail to modify disease progression, emphasizing the urgent need for novel, mechanism‐based interventions. Recent advances in molecular neuroscience have identified several non‐classical pathogenic pathways, including neuroinflammation, mitochondrial dysfunction, impaired autophagy and proteostasis, synaptic degeneration and non‐coding RNA dysregulation. In this focused review, we highlight emerging molecular targets such as TREM2, NLRP3, mTOR, TFEB, PINK1 and SIRT3, which offer promising avenues for therapeutic intervention. We also address challenges in target validation and translational drug development, while proposing future research directions that may facilitate the design of more effective treatments. A deeper understanding of these molecular mechanisms is essential for developing disease‐modifying strategies to combat neurodegeneration.

Subjects

MeSH terms (MEDLINE)

Neurodegenerative DiseasesMolecular Targeted TherapyHumansAnimalsAutophagyDrug Development

Author keywords

Alzheimer's diseaseautophagymolecular targetsneurodegenerationneuroinflammation

Authors and institutions

  • Department of Clinical Trials, Turkish Medicines and Medical Devices Agency, Ankara, Turkey.
  • Department of Medical Pharmacology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

ORCID profiles: Ezgi Eroglu, Nusin Harmanci

Cite

APA

Eroglu, E., & Harmanci, N. (2025). Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention. Basic & Clinical Pharmacology & Toxicology, 137(4). https://doi.org/10.1111/bcpt.70107

Vancouver

Eroglu E, Harmanci N. Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention. Basic & Clinical Pharmacology & Toxicology. 2025;137(4). doi:10.1111/bcpt.70107

BibTeX
@article{Eroglu2025,
  author = {Eroglu, Ezgi and Harmanci, Nusin},
  title = {Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention},
  journal = {Basic & Clinical Pharmacology & Toxicology},
  year = {2025},
  volume = {137},
  number = {4},
  doi = {10.1111/bcpt.70107}
}
Start for free →